← Back to headlines
Akebia Therapeutics Q4 Earnings Report
Akebia Therapeutics reported a GAAP EPS of -$0.05, missing estimates, while its revenue of $57.6 million beat expectations.
26 Feb, 12:07 — 26 Feb, 12:07
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Slovakia Resumes Sale of Government Bonds to Citizens with Favorable Interest Rates
11m ago
Trump Accounts for Kids Not Tax-Free, Advisor Explains How They Work
12m ago
If you can’t beat the market, you’d better hope it falls
12m ago
Lithuanian Social Insurance Fund 'Sodra' Reminds 39,000 People to Claim Unpaid Sickness Benefits
13m ago